Interesting that the FDA had no issue with Jakafi and their statistical methods where they used a lower null hypothesis on their single arm study of 40% and 20% as clinically meaningful effect
Seeking Alpha hatchet job, page-124
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.040(4.52%) |
Mkt cap ! $1.061B | |||
| Open | High | Low | Value | Volume |
| 88.5¢ | 95.0¢ | 88.0¢ | $2.793M | 3.045M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 30148 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 77340 | 11 |
View Market Depth
| Last trade - 11.58am 06/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |